Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels

Clinical trial NCT05525338 · RECRUITING

Trial details

NCT number: NCT05525338
Sponsor: University Medical Center Groningen
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Drug Monitoring Carcinoma, Non-Small-Cell Lung Lung Cancer Anaplastic Lymphoma Kinase Gene Mutation Anaplastic Lymphoma Kinase Gene Translocation

Start date: 2022-03-23
Primary completion: 2025-12-31
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.